비교리스트

 카트 문의
시장보고서
상품코드
1545580

세계의 대장균 검사 시장

E. Coli Testing
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 159 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 대장균 검사 시장은 2030년까지 32억 달러에 달할 것으로 전망

2023년 23억 달러로 추정되는 세계 대장균 검사 시장은 2023년부터 2030년까지 연평균 5.1% 성장하여 2030년에는 32억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 환경 검사 최종 용도는 CAGR 5.7%를 기록하여 분석 기간 동안 20억 달러에 달할 것으로 예상됩니다. 임상 검사 분야의 성장률은 분석 기간 동안 4.2%의 CAGR을 기록할 것으로 추정됩니다.

미국 시장 6억 1,140만 달러로 추정, 중국은 CAGR 8.6%로 성장 전망

미국의 대장균 검사 시장은 2023년 6억 1,140만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 7억 370만 달러의 시장 규모에 도달할 것으로 예상되며, 2023-2030년 분석 기간 동안 8.6%의 CAGR을 기록할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 1.6%와 5.6%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 연평균 2.7%의 성장률을 보일 것으로 예상됩니다.

세계 대장균 검사 시장 - 주요 동향 및 촉진요인 정리

대장균 검사란 무엇이며 왜 중요한가?

대장균 검사는 분변 오염 및 유해한 병원균의 잠재적 존재를 나타내는 대장균의 존재를 감지하기 위해 임상 및 환경 설정 모두에서 사용되는 중요한 절차입니다. 이 검사는 식중독 발생을 예방하고 수질을 보장하는 데 필수적입니다. 대장균은 대부분 무해하지만 E. coli O157과 같이 심한 복통, 설사 및 구토를 유발하는 병원성 유형도 있습니다. 이러한 박테리아를 신속하고 정확하게 검출하는 것은 의료 분야에서는 감염병을 효과적으로 관리하고 치료하기 위해 공중 보건 분야에서는 오염된 식품과 물 공급으로 인한 광범위한 발병을 예방하기 위해 매우 중요합니다.

대장균 검사는 어떻게 발전해 왔습니까?

대장균 검사를 뒷받침하는 조사 방법은 기존의 배양 기반 검사에서 보다 신속한 분자 기술로 크게 발전했습니다. 기존의 방법은 신뢰도가 낮고 결과가 나오기까지 며칠이 걸렸지만, 중합효소 연쇄 반응(PCR)이나 효소결합면역흡착법(ELISA)과 같은 최신 분자 기술은 몇 시간 내에 결과를 얻을 수 있습니다. 이러한 치료법의 발전은 의료 전문가와 식품 안전 전문가가 잠재적인 발병을 파악하고 필요한 조치를 취하는 데 필요한 시간을 크게 단축시켜 공중 보건 위험을 최소화하고 식품 제조 및 수처리 시설의 안전 프로토콜을 개선할 수 있도록 돕습니다.

대장균 검사의 미래를 좌우할 기술은 무엇일까?

생명공학 및 미생물학의 새로운 기술은 대장균 검사의 효율성과 정확성을 더욱 향상시키고 있으며, CRISPR 기반 바이오센서 및 차세대 염기서열 분석(NGS)과 같은 혁신은 박테리아 균주의 신속한 식별에 새로운 기준을 세우고 있습니다. 이러한 기술은 검출 시간을 단축할 뿐만 아니라 항생제 내성 프로파일을 식별할 수 있는 능력을 제공하여 치료 및 중재의 전략적 적용을 강화합니다. 또한, 진단 과정에 인공지능(AI)을 통합하는 것은 발병을 예측하고 다양한 환경에서 대장균 수치를 모니터링하는 알고리즘을 통해 적극적인 공중보건 조치를 지원하는 데 있어 매우 중요한 역할을 하기 시작했습니다.

대장균 검사 시장 확대의 원동력은?

대장균 검사 시장의 성장 원동력은 여러 부문에서 신속하고 신뢰할 수 있는 검사 솔루션에 대한 수요 증가를 반영하는 몇 가지 요인을 들 수 있습니다. 공중 보건에 대한 인식과 식품 안전 및 수질에 대한 엄격한 규제 기준이 주요 성장 촉진요인입니다. 세계 식품 공급망이 복잡해짐에 따라 효과적인 미생물 모니터링의 필요성이 증가하고 있으며, 소비자 안전을 보장하기 위한 견고한 검사 프로토콜이 필요합니다. 보다 빠르고 정확한 검사 옵션을 제공하는 기술의 발전도 시장 확대에 크게 기여하고 있습니다. 또한, 건강에 대한 관심이 높아지고 대장균 관련 질병 발생이 증가함에 따라 식음료 업계와 물 관리 당국은 더 나은 검사 및 탐지 시스템에 투자할 수밖에 없는 상황입니다. 이러한 역학은 기술 혁신, 규제 요구, 그리고 대중의 안전과 건강에 대한 필수적인 요구가 시장을 주도하고 있다는 것을 뒷받침합니다.

조사 대상 기업 예시(총 14건)

  • Accugen Laboratories, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • Eiken Chemical Co.
  • Enzo Life Sciences, Inc.
  • InstantLabs
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Mobidiag
  • Pro-Lab Diagnostics, Inc.
  • QIAGEN GmbH
  • Romer Labs, Inc.
  • Vivione Biosciences, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 24.09.10

Global E. Coli Testing Market to Reach US$3.2 Billion by 2030

The global market for E. Coli Testing estimated at US$2.3 Billion in the year 2023, is expected to reach US$3.2 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Environmental Testing End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Clinical Testing End-Use segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$611.4 Million While China is Forecast to Grow at 8.6% CAGR

The E. Coli Testing market in the U.S. is estimated at US$611.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$703.7 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global E. Coli Testing Market - Key Trends and Drivers Summarized

What Is E. Coli Testing and Why Is It Crucial?

E.coli testing is a critical procedure used in both clinical and environmental settings to detect the presence of Escherichia coli bacteria, which can indicate fecal contamination and the potential presence of harmful pathogens. This testing is essential in preventing outbreaks of foodborne illnesses and ensuring water quality. E. coli strains, while often harmless, can include virulent types such as E. coli O157, which cause severe abdominal cramps, diarrhea, and vomiting. Rapid and accurate detection of these bacteria is crucial in healthcare to manage and treat infections effectively and in public health to prevent widespread outbreaks from contaminated food or water supplies.

How Has E. Coli Testing Evolved Over the Years?

The methodology behind E. coli testing has seen substantial advancements, moving from traditional culture-based tests to more rapid molecular techniques. Traditional methods, while reliable, require several days to yield results, whereas modern molecular techniques, such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assays (ELISA), can provide results within hours. These advancements significantly reduce the time health professionals and food safety experts need to identify potential outbreaks and implement necessary controls, thereby minimizing public health risks and improving safety protocols in food production and water treatment facilities.

What Technologies Are Shaping the Future of E. Coli Testing?

Emerging technologies in biotechnology and microbiology are further refining the efficiency and accuracy of E. coli testing. Innovations such as CRISPR-based biosensors and next-generation sequencing (NGS) are setting new standards in the rapid identification of bacterial strains. These technologies offer not only faster detection times but also the ability to identify antibiotic resistance profiles, enhancing the strategic application of treatments and interventions. Additionally, the integration of artificial intelligence (AI) in diagnostic processes is beginning to play a pivotal role, with algorithms that can predict outbreaks and automate the monitoring of E. coli levels in various environments, thus supporting proactive public health measures.

What Drives the Expansion of the E. Coli Testing Market?

The growth in the E. coli testing market is driven by several factors, reflecting an increased demand for fast, reliable testing solutions across multiple sectors. Public health awareness and stringent regulatory standards concerning food safety and water quality are primary growth drivers. As global food supply chains become more complex, the need for effective microbial monitoring escalates, necessitating robust testing protocols to ensure consumer safety. Technological advancements that offer quicker, more accurate testing options are also major contributors to market expansion. Furthermore, the rise in health-conscious consumer behavior, coupled with an increase in outbreaks of E. coli-related illnesses, compels food and beverage industries and water management authorities to invest in better testing and detection systems. These dynamics underscore a market driven by innovation, regulatory demands, and the essential need for public safety and health.

Select Competitors (Total 14 Featured) -

  • Accugen Laboratories, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • Eiken Chemical Co., Ltd.
  • Enzo Life Sciences, Inc.
  • InstantLabs
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Mobidiag
  • Pro-Lab Diagnostics, Inc.
  • QIAGEN GmbH
  • Romer Labs, Inc.
  • Vivione Biosciences, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • E. Coli Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Incidence of Foodborne Illnesses Drives Demand for E. Coli Testing Solutions
    • Advances in Molecular Diagnostic Technologies Propel Growth in E. Coli Testing Market
    • Increasing Focus on Food Safety and Regulatory Compliance Strengthens Business Case for E. Coli Testing
    • Expansion of E. Coli Testing in Water and Environmental Monitoring Spurs Demand for Rapid Detection Solutions
    • Growing Applications of E. Coli Testing in Agriculture and Animal Husbandry Drive Market Expansion
    • Rising Demand for E. Coli Testing in Water Treatment and Quality Control Expands Addressable Market
    • Growing Emphasis on Consumer Awareness and Education Drives Adoption of E. Coli Testing in Retail and Food Service
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for E. Coli Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Environmental Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Environmental Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Environmental Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Clinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Clinical Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World E. Coli Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • JAPAN
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • CHINA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • EUROPE
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for E. Coli Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • FRANCE
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • GERMANY
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for E. Coli Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • INDIA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: India Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: India 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for E. Coli Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for E. Coli Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • AFRICA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제